A5012921783- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Psoriasis: Treatment and Pathogenesis
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Lipoproteins and Cardiovascular Health
- Cardiac Structural Anomalies and Repair
- Cardiovascular Disease and Adiposity
- Acute Myocardial Infarction Research
- Cardiac Arrest and Resuscitation
- Cerebrovascular and Carotid Artery Diseases
- Aortic Disease and Treatment Approaches
- Cardiac electrophysiology and arrhythmias
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Peripheral Artery Disease Management
- Heart Failure Treatment and Management
- Cardiovascular Issues in Pregnancy
- Cardiovascular Health and Disease Prevention
- Mobile Health and mHealth Applications
- COVID-19 Clinical Research Studies
Icahn School of Medicine at Mount Sinai
2017-2025
Mount Sinai Hospital
2020-2025
Cardiovascular Institute of the South
2011-2025
Mount Sinai Hospital
2020-2024
Mount Sinai Medical Center
2020-2024
Mount Sinai Health System
2016-2024
West Virginia University
2024
Hackensack Meridian Health
2023
Mount Sinai Hospital
2022
Meenakshi Mission Hospital and Research Centre
2020
Objective— To understand whether directly measured psoriasis severity is associated with vascular inflammation assessed by 18 F-fluorodeoxyglucose positron emission tomography computed tomography. Approach— In-depth cardiovascular and metabolic phenotyping was performed in adult patients (n=60) controls (n=20). Psoriasis using area index. Vascular average aortic target-to-background ratio Results— Both the (28 men 32 women, mean age 47 years) (13 7 41 were young low risk. index scores...
GlycA, an emerging inflammatory biomarker, predicted cardiovascular events in population-based studies. Psoriasis, disease associated with increased risk, provides a model to study biomarkers (CVD). Whether GlycA associates psoriasis and how it predicts subclinical CVD beyond high-sensitivity C-reactive protein is unknown.To investigate the relationships between CVD.Patients controls (n=412) participated 2-stage study. We measured by nuclear magnetic resonance spectroscopy. National...
Cannabis for medicinal and/or recreational purposes has been decriminalized in 28 states as of the 2016 election. In remaining states, cannabis remains most commonly used illicit drug. Cardiovascular effects use are not well established due to a limited number studies. We therefore utilized large national database examine prevalence cardiovascular risk factors and events amongst patients with use.Patients aged 18-55 years were identified National Inpatient Sample 2009-2010 using Ninth...
Psoriasis, especially when severe, is a risk factor for cardiometabolic disease beyond traditional factors. The mechanism of atherogenesis in psoriasis remains unknown. Cell membrane vesicles (ie, microparticles), released upon cell activation or apoptosis, have recently been associated with and may play pathogenic role. Microparticle levels, particularly from endothelial cells platelets, are elevated patients cardiovascular disorders, metabolic syndrome, other inflammatory diseases,...
COVID-19 infection can affect the cardiovascular system. We sought to determine if left ventricular global longitudinal strain (LVGLS) is affected by and this has prognostic implications. Materials & methods: Retrospective study, with LVGLS was measured in 58 patients. Patients discharged were compared those who died. Results: The mean LV ejection fraction (LVEF) for cohort 52.1 -12.9 ± 4.0%, respectively. Among 30 patients preserved LVEF (>50%), -15.7 2.8%, which lower than reference a...
Numerous case series have reported on the baseline characteristics and in-hospital mortality of patients with COVID-19, however, these studies included localized in a specific geographic region. The purpose our study was to identify differences clinical laboratory-confirmed diagnosis COVID-19 internationally. A comprehensive search all published literature adult that performed. Groups were compared using Chi-square test Yates correction continuity. two-tailed p value less than 0.05...
Abstract Aims To evaluate the acute and chronic patterns of myocardial injury among patients with coronavirus disease-2019 (COVID-19), their mid-term outcomes. Methods results Patients laboratory-confirmed COVID-19 who had a hospital encounter within Mount Sinai Health System (New York City) between 27 February 2020 15 October were evaluated for inclusion. Troponin levels assessed 72 h before 48 after diagnosis used to stratify study population by presence injury, as defined Fourth Universal...
BACKGROUND: Redo-transcatheter aortic valve replacement (TAVR) can pin the index transcatheter heart leaflets open leading to sinus sequestration and restricting coronary access. The impact of initial implant depth commissural alignment on redo-TAVR feasibility is unclear. We sought determine access after SAPIEN 3 (S3) TAVR stratified by alignment. METHODS: Consecutive patients with native stenosis were evaluated using multidetector computed tomography. S3 simulations done at depths, sizing...
Importance It is well appreciated that a small yet high-risk subset of patients with atrial fibrillation (AF) develops persistent left appendage (LAA) thrombus despite optimal oral anticoagulation (OAC). In either heightened risk bleeding precluding enhanced doses OAC to dissolve the thrombus, or thromboembolism OAC, there are limited nonsurgical options. Objectives To introduce novel management strategy for resistant LAA thrombus: percutaneous mechanical aspiration cerebral protection,...
Identifying alternative contributors to the residual risk of atherosclerotic cardiovascular disease (ASCVD) beyond LDL cholesterol (LDL-C) levels is crucial. We investigated relative impact triglycerides (TGs) and high-sensitivity C-reactive protein (hs-CRP) on outcomes in statin-treated patients with well-controlled LDL-C undergoing percutaneous coronary intervention (PCI) for established ASCVD. included 9446 < 70 mg/dL PCI between 2012 2022, stratified into four groups: (i) no (TG <150 +...